Tempest Therapeutics, Inc.TPSTNASDAQ
Loading
Operating Expenses Over TimeContracting
Percentile Rank64
3Y CAGR+1.6%
5Y CAGR+14.4%
Year-over-Year Change
Expenses from normal business operations (SG&A, R&D, etc.)
3Y CAGR
+1.6%/yr
vs +10.7%/yr prior
5Y CAGR
+14.4%/yr
Recent deceleration
Acceleration
-9.1pp
Decelerating
Percentile
P64
Within normal range
vs 5Y Ago
2x
Strong expansion
Streak
1 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| TTM | $36.28M | -12.9% |
| 2024 | $41.64M | +42.8% |
| 2023 | $29.16M | -15.8% |
| 2022 | $34.64M | +28.4% |
| 2021 | $26.99M | +46.0% |
| 2020 | $18.48M | -58.3% |
| 2019 | $44.35M | +92.1% |
| 2018 | $23.08M | +12.9% |
| 2017 | $20.45M | -71.1% |
| 2016 | $70.86M | - |